NCT04926220

Brief Summary

During major surgery, it is recommended to monitor invasive arterial blood pressure and cardiac output (CO) during hemodynamic interventions (fluid challenge or vasopressors). Esophageal Doppler is currently considered as the reference method for monitoring cardiac output in the operating room. The PRAM method (pressure recording analytical method) with the MostCareUp monitor (Vytech, Padova, Italy) and the LTIA method (long time interval analysis) allow cardiac output estimation derived from non-calibrated arterial pressure waveform analysis. Few studies have looked at relative changes in cardiac output during hemodynamic intervention with these two methods. The aim of this study is to compare the relative changes in cardiac output during hemodynamic interventions as measured using PRAM and LTIA methods, compared to esophageal Doppler.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
92

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 15, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

September 15, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

October 18, 2021

Status Verified

June 1, 2021

Enrollment Period

2 years

First QC Date

June 7, 2021

Last Update Submit

October 11, 2021

Conditions

Keywords

Cardiac output monitoringPulse contour analysisVasopressorsFluid challengeTrans-esophageal dopplerPressure recording analytical methodLong time interval analysis

Outcome Measures

Primary Outcomes (3)

  • Cardiac output using the trans-esophageal Doppler technique

    Measure of cardiac output with trans-esophageal doppler (CARDIOQ-ODM; Deltex Medical, Chichester, UK) in L/min (COTOD)

    Duration of the surgery (maximum 1 day)

  • Cardiac output using the MostCareUp monitor

    Measure of cardiac output with MostCareUp (Vytech, Padova, Italy) in L/min (COPRAM)

    Duration of the surgery (maximum 1 day)

  • Cardiac output using the Argos monitor

    Measure of cardiac output with Argos monitor (Retia Medical, Valhalla, NY, USA) in L/min (COLTIA)

    Duration of the surgery (maximum 1 day)

Secondary Outcomes (7)

  • Measure of the value of the dicrote wave with MostCareUp monitor

    Duration of the surgery (maximum 1 day)

  • Measure of dP/dtmax (myocardial contractility index) with MostCareUp monitor

    Duration of the surgery (maximum 1 day)

  • Measure of the cardiac efficiency (CCE) with MostCareUp monitor

    Duration of the surgery (maximum 1 day)

  • Measure of arterial elastance with MostCareUp monitor

    Duration of the surgery (maximum 1 day)

  • Measure of the total impedance of the system (Ztot) with MostCareUp monitor

    Duration of the surgery (maximum 1 day)

  • +2 more secondary outcomes

Study Arms (1)

Patients undergoing general anesthesia and benefiting from intraoperative hemodynamic optimization

Patients undergoing general anesthesia and benefiting from intraoperative hemodynamic optimization, including routine monitoring of blood pressure and measurement of cardiac output by trans-esophageal Doppler.

Device: Trans-esophageal Doppler monitoringDevice: MostCareUP Haemodynamic MonitorDevice: Argos Cardiac Output (CO) Monitor

Interventions

Trans-esophageal Doppler monitoring (CARDIOQ-ODM; Deltex Medical, Chichester, UK) for monitoring of cardiac output

Patients undergoing general anesthesia and benefiting from intraoperative hemodynamic optimization

MostCareUp (Vytech, Padova, Italy) waveform analysis cardiac output monitor

Patients undergoing general anesthesia and benefiting from intraoperative hemodynamic optimization

Argos monitor (Retia Medical, Valhalla, NY, USA) for cardiac output monitoring

Patients undergoing general anesthesia and benefiting from intraoperative hemodynamic optimization

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients eligible for an interventional radiology procedure, surgery under general anesthesia, or admitted to intensive care unit for postoperative organ failure, benefiting from intraoperative and postoperative hemodynamic optimization in intensive care including routine blood pressure monitoring and measurement of cardiac output by esophageal Doppler.

You may qualify if:

  • Major patients (≥ 18 years )
  • Eligible for an interventional radiology procedure or surgery under general anesthesia
  • Monitoring of invasive blood pressure and cardiac output by trans-esophageal Doppler.
  • Patients informed and having expressed their non-opposition to participation in this research

You may not qualify if:

  • Patients under 18 years old
  • Atrial fibrillation
  • Contraindication to trans-esophageal doppler
  • Patient opposed to protocol participation
  • Pregnant woman
  • Patient under judicial protection
  • Patient without affiliation to a social security scheme

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AP-HP, Lariboisière Hospital, Department of Anesthesiology and Intensive Care

Paris, 75010, France

RECRUITING

MeSH Terms

Interventions

Monitoring, Physiologic

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Alex HONG, MD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR
  • Joaquim MATEO, MD

    Assistance Publique - Hôpitaux de Paris

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2021

First Posted

June 15, 2021

Study Start

September 15, 2021

Primary Completion

September 1, 2023

Study Completion

March 1, 2024

Last Updated

October 18, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations